GMP Standard Uracil API Precursor Quality Assurance COA

• [Synthetic Pathway]: Optimized condensation routes ensuring ≥99.5% assay with minimal impurity profiles.
• [Vendor Vetting]: Factory-direct sourcing models that stabilize bulk price fluctuations and lead times.
• [Audit Readiness]: Full documentation packages including COA, SDS, and GMP standard compliance records.

In the high-stakes environment of pharmaceutical manufacturing, the integrity of starting materials dictates the success of the final Active Pharmaceutical Ingredient (API). Uracil (CAS: 66-22-8), chemically known as 2,4(1H,3H)-Pyrimidinedione, serves as a fundamental API precursor for the synthesis of antiviral and anticancer nucleosides. Procuring this heterocyclic compound requires more than just a transaction; it demands a partnership rooted in technical transparency and regulatory adherence. At NINGBO INNO PHARMCHEM CO.,LTD., we prioritize process-scale purity and documented quality assurance to support global supply chains.

Understanding GMP Certification for Intermediates

The transition from laboratory-scale synthesis to commercial production introduces complex variables that can impact product stability. A robust manufacturing process is essential to maintain the structural integrity of the pyrimidine ring during scale-up. Our facilities operate under strict GMP standard guidelines, ensuring that every batch of Uracil meets the rigorous demands of downstream pharmaceutical applications. This compliance is not merely ceremonial; it involves validated cleaning procedures, calibrated equipment, and controlled environmental conditions that prevent cross-contamination.

For executive decision-makers, the economic viability of a synthesis campaign relies on the reliability of the raw material supply. Variability in the precursor can lead to failed batches, increased waste, and regulatory delays. By selecting a global manufacturer with established quality systems, companies mitigate the risk of supply chain disruptions. Our approach integrates ISO 9001:2015 certification with cGMP protocols, providing a dual layer of assurance that satisfies both quality assurance teams and regulatory auditors.

Interpreting HPLC Purity and COA Data

For process chemists and R&D leads, the Certificate of Analysis (COA) is the primary document for verifying material suitability. A comprehensive COA must go beyond simple identity confirmation. It should detail quantitative data regarding impurities, residual solvents, and heavy metals. When evaluating a potential nucleobase supplier, scrutinize the HPLC methods used. High-performance liquid chromatography should demonstrate a main peak area percentage consistent with high-grade material, typically exceeding 99.5%.

Impurity profiling is critical. Unidentified peaks in the chromatogram can indicate side reactions from the cyclization step or incomplete purification. Our quality control laboratory utilizes NMR and FTIR alongside HPLC to confirm molecular structure and detect trace contaminants. This multi-method verification ensures that the Uracil supplied is fit for sensitive coupling reactions used in nucleoside analog synthesis.

Parameter	Specification	Test Method
Product Name	Uracil	Visual / COA
CAS Number	66-22-8	N/A
Chemical Formula	C4H4N2O2	N/A
Purity (HPLC)	≥ 99.5%	USP / EP Method
Loss on Drying	≤ 0.5%	Karl Fischer Titration
Residue on Ignition	≤ 0.1%	Gravimetric
Heavy Metals	≤ 10 ppm	ICP-MS
Storage Conditions	Cool, dry, dark place. Tightly sealed.	N/A

Heavy Metals and Residue Testing Protocols

Regulatory compliance extends to safety parameters such as heavy metal content and residual solvents. Elements like lead, arsenic, and mercury must be controlled to ppm levels to meet International Council for Harmonisation (ICH) guidelines. Our testing protocols employ ICP-MS for precise quantification of elemental impurities. Furthermore, residual solvents from the recrystallization process are analyzed via Gas Chromatography (GC) to ensure they fall within permissible daily exposure limits.

For procurement specialists, understanding these specifications is vital when negotiating contracts. The cost of goods sold (COGS) should reflect the value of this rigorous testing. While some vendors may offer a lower bulk price, the hidden costs of additional in-house testing or batch rejection can outweigh initial savings. Sourcing from a factory supply chain that guarantees these specifications upfront protects the overall project budget and timeline.

Strategic Sourcing and Supply Chain Stability

Reliability in the supply chain is as critical as chemical quality. Fluctuations in raw material availability can stall production lines. When sourcing high-purity industrial purity industrial purity materials, buyers should prioritize manufacturers with redundant sourcing strategies for key reagents like urea and malonic acid derivatives. This ensures continuity even during market shortages.

NINGBO INNO PHARMCHEM CO.,LTD. maintains strategic inventory levels to facilitate quicker turnaround for urgent requests. Our logistics team manages all necessary customs documentation for international shipments, ensuring smooth clearance and delivery. Whether requiring kilogram-scale samples for R&D or tonnage quantities for commercial production, our flexible manufacturing capabilities adapt to diverse project requirements.

Conclusion and Technical Support

Securing a reliable source of Uracil is a strategic decision that impacts product quality, development timelines, and market success. By prioritizing GMP compliance, detailed COA verification, and scalable production capabilities, pharmaceutical companies can safeguard their synthesis campaigns against quality failures.

To ensure your next project meets all technical and regulatory requirements, we invite you to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. Our specialists are ready to collaborate on your specific synthesis challenges and provide the documentation needed for your vendor qualification process.